{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "10"
        },
        "variant_string_id": "DJ-1 L10P"
      },
      "functional_evidence_aim": "Pathogenic",
      "step_1": {
        "disease_mechanism_defined": true,
        "judgment": "Yes",
        "reason": "The paper explicitly states that L10P and P158DEL mutations are pathogenic, causing early-onset parkinsonism through mechanisms like reduced protein stability, proteasome degradation, and impaired dimerization."
      },
      "step_2": {
        "assay_applicability": true,
        "judgment": "Proceed to Step 3",
        "reason": "Assays (protein stability, solubility, dimerization) directly relate to DJ-1's functional role in cellular processes, which are implicated in the disease mechanism."
      },
      "step_3": {
        "sub_step_3a": {
          "controls_replicates": true,
          "judgment": "Proceed to Step 3c",
          "reason": "The study compares L10P/P158DEL to WT and L166P (a known pathogenic variant), implying the use of both benign and pathogenic controls. While replicates are not explicitly mentioned, the experimental design suggests sufficient controls."
        },
        "sub_step_3c": {
          "variant_controls_used": true,
          "judgment": "Proceed to Step 4",
          "reason": "Known pathogenic variant (L166P) and WT (benign) are used as controls, meeting the criteria for variant-specific controls."
        }
      },
      "step_4": {
        "sub_step_4a": {
          "statistical_analyses": false,
          "judgment": "Proceed to Sub-step 4b",
          "reason": "The paper does not report p-values, effect sizes, or OddsPath calculations explicitly."
        },
        "sub_step_4b": {
          "number_of_controls": "Unclear but likely sufficient",
          "judgment": "Max PS3_supporting / Max BS3_supporting",
          "reason": "The study includes multiple variant comparisons (L10P, P158DEL, L166P vs. WT), but exact control counts are unspecified. However, the presence of both benign and pathogenic controls implies adequate statistical power."
        }
      },
      "final_strength": "PS3_supporting",
      "reason": "The variants demonstrate significant functional impairments (e.g., reduced stability, proteasome degradation, and loss of dimerization) relative to WT and a known pathogenic variant. These findings align with pathogenic classification under ACMG criteria."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "P",
          "alt": "DEL",
          "position": "158"
        },
        "variant_string_id": "DJ-1 P158DEL"
      },
      "functional_evidence_aim": "Pathogenic",
      "step_1": {
        "disease_mechanism_defined": true,
        "judgment": "Yes",
        "reason": "The paper explicitly states that P158DEL is pathogenic, causing early-onset parkinsonism through mechanisms like reduced protein stability, proteasome degradation, and impaired dimerization."
      },
      "step_2": {
        "assay_applicability": true,
        "judgment": "Proceed to Step 3",
        "reason": "Assays (protein stability, solubility, dimerization) directly relate to DJ-1's functional role in cellular processes, which are implicated in the disease mechanism."
      },
      "step_3": {
        "sub_step_3a": {
          "controls_replicates": true,
          "judgment": "Proceed to Step 3c",
          "reason": "The study compares P158DEL to WT and L166P (a known pathogenic variant), implying the use of both benign and pathogenic controls. While replicates are not explicitly mentioned, the experimental design suggests sufficient controls."
        },
        "sub_step_3c": {
          "variant_controls_used": true,
          "judgment": "Proceed to Step 4",
          "reason": "Known pathogenic variant (L166P) and WT (benign) are used as controls, meeting the criteria for variant-specific controls."
        }
      },
      "step_4": {
        "sub_step_4a": {
          "statistical_analyses": false,
          "judgment": "Proceed to Sub-step 4b",
          "reason": "The paper does not report p-values, effect sizes, or OddsPath calculations explicitly."
        },
        "sub_step_4b": {
          "number_of_controls": "Unclear but likely sufficient",
          "judgment": "Max PS3_supporting / Max BS3_supporting",
          "reason": "The study includes multiple variant comparisons (P158DEL, L10P, L166P vs. WT), but exact control counts are unspecified. However, the presence of both benign and pathogenic controls implies adequate statistical power."
        }
      },
      "final_strength": "PS3_supporting",
      "reason": "The variant demonstrates significant functional impairments (e.g., reduced stability, proteasome degradation, and loss of dimerization) relative to WT and a known pathogenic variant. These findings align with pathogenic classification under ACMG criteria."
    }
  ]
}